本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

4D Molecular Therapeutics

4.64
+0.07001.53%
盘后4.61-0.0300-0.65%16:10 EDT
成交量:26.64万
成交额:124.36万
市值:2.15亿
市盈率:-1.46
高:4.75
开:4.58
低:4.53
收:4.57
数据加载中...

公司资料

公司名字:
4D Molecular Therapeutics
交易所:
NASDAQ
成立时间:
2013
员工人数:
227
公司地址:
5858 Horton Street,Suite 455,Emeryville,California,United States
邮编:
94608
电话:
传真:
- -
简介:
4D Molecular Therapeutics, Inc.于2015年3月11日根据特拉华州法律成立。该公司是一家领先的临床阶段生物制药公司,专注于通过针对特定疾病治疗进行优化的专有定制载体释放基因药物的全部潜力。

董事

名称
职位
David Kirn
Director and Chief Executive Officer
John F. Milligan
Executive Chairman of the Board
Charles Theuer
Independent Director
Jacob Chacko
Independent Director
Nancy Miller Rich
Independent Director
Shawn Cline Tomasello
Independent Director
Susannah Gray
Independent Director

股东

名称
职位
David Kirn
Director and Chief Executive Officer
Fariborz Kamal
President and Chief Operating Officer
John F. Milligan
Executive Chairman of the Board
Noriyuki Kasahara
Chief Scientific Officer
Robert Young Kim
Chief Medical Officer
Scott Bizily
Chief Legal Officer and Corporate Secretary